source
- Flagship Pioneering merges three portfolio companies to boost AI drug discoveryFlagship Pioneering, a biotech incubator based in Cambridge, Massachusetts, announced it is merging three of its portfolio companies into a single organization. The consolidation includes a compan…
- BMS drops $80 million neurodegeneration program after phase-1 resultsBMS announced it will not move forward with a neurodegeneration drug it licensed from Prothena, ending a program it invested $80 million in. The drug, known as BMS-986495 (formerly PRX019), comple…